A development-stage diagnostics company had developed a new technology to assess disease activity with a simple test. The technology had great potential, but pursuing it would be disruptive for the company.

A middle market private equity firm (Client) was conducting due diligence on a provider of chronic care management (CCM) and remote patient monitoring (RPM) services. Client engaged HBG for market and regulatory diligence

A real estate investor with little health care experience sought commercial due diligence support to evaluate a fast growing contract development and manufacturing organization. Client needed to understand industry demand, competitive dynamics, and the potential of the company’s customer relationships.